2LPN
| Solution Structure of N-Terminal domain of human Conserved Dopamine Neurotrophic Factor (CDNF) | Descriptor: | Cerebral dopamine neurotrophic factor | Authors: | Latge, C, Cabral, K.M.S, Foguel, D, Pires, J.R.M, Almeida, M.S. | Deposit date: | 2012-02-15 | Release date: | 2013-02-20 | Last modified: | 2024-10-30 | Method: | SOLUTION NMR | Cite: | (1)H-, (13)C- and (15)N-NMR assignment of the N-terminal domain of human cerebral dopamine neurotrophic factor (CDNF). Biomol.Nmr Assign., 7, 2013
|
|
3TFB
| Transthyretin natural mutant A25T | Descriptor: | Transthyretin | Authors: | Azevedo, E.P.C, Pereira, H.M, Garratt, R.C, Kelly, J.W, Foguel, D, Palhano, F.L. | Deposit date: | 2011-08-15 | Release date: | 2011-12-07 | Last modified: | 2023-09-13 | Method: | X-RAY DIFFRACTION (2.033 Å) | Cite: | Dissecting the Structure, Thermodynamic Stability, and Aggregation Properties of the A25T Transthyretin (A25T-TTR) Variant Involved in Leptomeningeal Amyloidosis: Identifying Protein Partners That Co-Aggregate during A25T-TTR Fibrillogenesis in Cerebrospinal Fluid. Biochemistry, 50, 2011
|
|
5DEJ
| Transthyretin natural mutant A19D | Descriptor: | CALCIUM ION, Transthyretin | Authors: | Pereira, H.M, Ferreira, P, Andrade, C, Lima, C, Palhano, F, Foguel, D. | Deposit date: | 2015-08-25 | Release date: | 2016-08-31 | Last modified: | 2024-03-06 | Method: | X-RAY DIFFRACTION (1.37 Å) | Cite: | Crystal structure of human Transthyretin natural mutant A19D To Be Published
|
|
3OZL
| |
3OZK
| Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4) | Descriptor: | 3,5,3',5'-TETRAIODO-L-THYRONINE, Transthyretin | Authors: | Lima, L.M.T.R, Palmieri, L.C, Foguel, D, Palhano, F.L. | Deposit date: | 2010-09-25 | Release date: | 2011-08-24 | Last modified: | 2023-11-15 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4) To be Published
|
|
4BIT
| solution structure of cerebral dopamine neurotrophic factor (CDNF) | Descriptor: | CEREBRAL DOPAMINE NEUROTROPHIC FACTOR | Authors: | Latge, C, Cabral, K.M.S, Raymundo, D.P, Foguel, D, Herrmann, T, Almeida, M.S. | Deposit date: | 2013-04-13 | Release date: | 2014-04-23 | Last modified: | 2024-10-16 | Method: | SOLUTION NMR | Cite: | The Solution Structure and Dynamics of Full-Length Human Cerebral Dopamine Neurotrophic Factor and its Neuroprotective Role Against Alpha-Synuclein Oligomers. J.Biol.Chem., 290, 2015
|
|
3CFN
| |
3CFT
| |
3CFQ
| |
3CFM
| |
3DID
| Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6 soaked | Descriptor: | ACETATE ION, GLYCEROL, Transthyretin, ... | Authors: | Palmieri, L.C, Freire, J.B.B, Foguel, D, Lima, L.M.T.R. | Deposit date: | 2008-06-20 | Release date: | 2008-07-22 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (1.78 Å) | Cite: | Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition. J.Biol.Chem., 285, 2010
|
|
3DGD
| Crystal structure of the F87M/L110M mutant of human transthyretin at pH 4.6 | Descriptor: | ACETATE ION, GLYCEROL, Transthyretin, ... | Authors: | Palmieri, L.C, Freire, J.B.B, Foguel, D, Lima, L.M.T.R. | Deposit date: | 2008-06-13 | Release date: | 2008-07-22 | Last modified: | 2023-08-30 | Method: | X-RAY DIFFRACTION (1.383 Å) | Cite: | Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition. J.Biol.Chem., 285, 2010
|
|
3GRB
| Crystal structure of the F87M/L110M mutant of human transthyretin at pH 6.5 | Descriptor: | ACETATE ION, GLYCEROL, Transthyretin, ... | Authors: | Palmieri, L.C, Freire, J.B.B, Foguel, D, Lima, L.M.T.R. | Deposit date: | 2009-03-25 | Release date: | 2010-04-07 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (1.75 Å) | Cite: | Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition. J.Biol.Chem., 285, 2010
|
|
3I9I
| Crystal structure of human transthyretin variant A25T - #2 | Descriptor: | TRIETHYLENE GLYCOL, Transthyretin | Authors: | Palmieri, L.C, Freire, J.B.B, Palhano, F.L, Azevedo, E.P.C, Foguel, D, Lima, L.M.T.R. | Deposit date: | 2009-07-11 | Release date: | 2011-02-23 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Crystal structure of human transthyretin variant A25T - #2 To be Published
|
|
3I9P
| |
3I9A
| Crystal structure of human transthyretin variant A25T - #1 | Descriptor: | TRIETHYLENE GLYCOL, Transthyretin | Authors: | Palmieri, L.C, Freire, J.B.B, Palhano, F.L, Azevedo, E.P.C, Foguel, D, Lima, L.M.T.R. | Deposit date: | 2009-07-10 | Release date: | 2010-08-25 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (1.65 Å) | Cite: | Crystal structure of human transthyretin variant A25T - #1 To be Published
|
|
3GRG
| Crystal structure of the F87M/L110M mutant of human transthyretin at pH 7.5 | Descriptor: | ACETATE ION, GLYCEROL, Transthyretin, ... | Authors: | Palmieri, L.C, Freire, J.B.B, Foguel, D, Lima, L.M.T.R. | Deposit date: | 2009-03-25 | Release date: | 2010-04-07 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition. J.Biol.Chem., 285, 2010
|
|
3GPS
| Crystal structure of the F87M/L110M mutant of human transthyretin at pH 5.5 | Descriptor: | ACETATE ION, GLYCEROL, Transthyretin, ... | Authors: | Palmieri, L.C, Freire, J.B.B, Foguel, D, Lima, L.M.T.R. | Deposit date: | 2009-03-23 | Release date: | 2010-04-07 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (1.78 Å) | Cite: | Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition. J.Biol.Chem., 285, 2010
|
|
3NEE
| Wild type human transthyretin (TTR) complexed with GC-1 (TTRwt:GC-1) | Descriptor: | GLYCEROL, Transthyretin, {4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid | Authors: | Trivella, D.B.B, Polikarpov, I. | Deposit date: | 2010-06-08 | Release date: | 2010-11-24 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (1.55 Å) | Cite: | The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition. J.Struct.Biol., 173, 2011
|
|
3NEX
| |
3NEO
| |
3NES
| V30M mutant human transthyretin (TTR) complexed with GC-1 (V30M:GC-1) | Descriptor: | GLYCEROL, Transthyretin, {4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid | Authors: | Trivella, D.B.B, Polikarpov, I. | Deposit date: | 2010-06-09 | Release date: | 2010-11-24 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (1.75 Å) | Cite: | The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition. J.Struct.Biol., 173, 2011
|
|
5LCN
| |
5FW6
| Structure of human transthyretin mutant A108V | Descriptor: | TRANSTHYRETIN | Authors: | Gallego, P, Varejao, N, Santanna, R, Saraiva, M.J, Ventura, S, Reverter, D. | Deposit date: | 2016-02-12 | Release date: | 2017-03-08 | Last modified: | 2024-05-08 | Method: | X-RAY DIFFRACTION (1.3 Å) | Cite: | Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation. Sci Rep, 7, 2017
|
|
3KGU
| |